genital warts. Anogenital (venereal) warts
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: Definite diagnosis of HPV Patients with more than two genital warts in genitalia (perinea, groin, anus) Age more than 18 Willingness to participate in the study
Exclusion criteria
Exclusion criteria: Inflammatory skin disease Rheumatological disease Malignancy Kidney and liver disease Eczema Diabetes mellitus Previous history of allergy to vitamin D Acquired immunodeficiency Pregnancy and lactation
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Measuring size and number of anogenital warts. Timepoint: Baseline visit, then every three week up to four sessions. Method of measurement: Lesion count, surgical grading ruler. | — |
Secondary
| Measure | Time frame |
|---|---|
| Qualitative evaluation of response to treatment (complete response, partial response 50-99%, no response less than 50%). Timepoint: Last treatment session. Method of measurement: Qualitative.;Patient's satisfaction. Timepoint: Last treatment session. Method of measurement: Qualitative evaluation (Very satisfied, Satisfied, Somehow satisfied, Unsatisfied). | — |
Countries
Iran (Islamic Republic of)
Contacts
Tehran University of Medical Sciences